{"nct_id":"NCT04716933","title":"Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)-China Extension Study","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2019-11-05","start_date_type":"ACTUAL","primary_completion_date":"2023-08-11","primary_completion_date_type":"ACTUAL","completion_date":"2024-08-30","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}